- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Crossject (ALCJ)
Assess today's live Crossject (ALCJ) share price, performance and insights using our live Paris: ALCJ stock exchange data.
Analyse the historical data and Crossject share price performance charts on this page. Our technical summary section provides analysis on Crossject share price buy/sell indicators using real-time data (or discuss the Crossject (ALCJ) stock price today with other investors in the Crossject EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA ALCJ share price (ISIN: FR0011716265) to enhance your trading decisions with our free investment tools and resources.
What Is the Crossject Share Price Today?
The Crossject share price today is 2.175.
What Is the Stock Symbol for Crossject
The stock symbol (or 'ticker') for Crossject is "ALCJ."
What Stock Exchange Does Crossject Trade On?
Crossject is listed and trades on the Paris stock exchange.
Is Crossject a Good Stock to Buy?
Determining whether Crossject—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Crossject share price performance charts on this page. Our technical summary section provides analysis on Crossject share price buy/sell indicators using real-time data (or discuss the Crossject (ALCJ) stock price today with other investors in the Crossject EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA ALCJ share price (ISIN: FR0011716265) to enhance your trading decisions with our free investment tools and resources.
What Is the Crossject Share Price Today?
The Crossject share price today is 2.175.
What Is the Stock Symbol for Crossject
The stock symbol (or 'ticker') for Crossject is "ALCJ."
What Stock Exchange Does Crossject Trade On?
Crossject is listed and trades on the Paris stock exchange.
Is Crossject a Good Stock to Buy?
Determining whether Crossject—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Paris
Currency in EUR
2.175
+0.005(+0.23%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.150
2.200
52 wk Range
0.720
2.695
ALCJ is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.1502.200
52 wk Range
0.7202.695
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALCJ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
4.300
Upside
+97.70%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Crossject reports audited financial results for 2023
- Investing.com
- Crossject reports audited financial results for 2023
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Crossject Company Profile
Crossject Société Anonyme develops needle-free injection systems in France. The company develops ZENEO, needle-free, pre-filled, single-use auto-injector. Its product pipeline includes Midazolam for epileptic seizure; Naloxone for opioid overdose; Terbutaline for the treatment of severe asthma crisis; Epinephrine for anaphylactic shock; and Sumatriptan for the treatment of migraine and cluster headaches, as well as Hydrocortisone for acute adrenal crisis and Methotrexate for the treatment of rheumatoid arthritis. In addition, the company is developing ZEPIZURE, an emergency treatment for managing epileptic seizures. The company was incorporated in 2001 and is based in Dijon, France.
Compare ALCJ to Peers and Sector
Metrics to compare | ALCJ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALCJPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.0x | −0.8x | −0.6x | |
PEG Ratio | −0.59 | −0.06 | 0.00 | |
Price/Book | −102.9x | 1.5x | 2.6x | |
Price / LTM Sales | 27.7x | 0.9x | 3.2x | |
Upside (Analyst Target) | 104.8% | 60.1% | 41.8% | |
Fair Value Upside | Unlock | 25.1% | 5.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.300
(+97.70% Upside)
Earnings
Latest Release
Oct 31, 2025
EPS / Forecast
-0.10 / --
Revenue / Forecast
1.54M / --
People Also Watch
FAQ
What Is the Crossject (ALCJ) Share Price Today?
The live Crossject share price today is 2.175
What Stock Exchange Does Crossject (ALCJ) Trade On?
Crossject is listed and trades on the Paris Stock Exchange.
What Is the Ticker (Stock Symbol) for Crossject?
The stock symbol (also called a 'ticker') for Crossject is "ALCJ."
What Is the Current Crossject Market Cap?
As of today, Crossject market capitalisation is 114.97M.
What Is Crossject's (ALCJ) Earnings Per Share (TTM)?
The Crossject EPS is currently -0.22 (Trailing Twelve Months).
Is ALCJ a Buy or Sell From a Technical Analyst Perspective?
Based on today's Crossject moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Crossject Stock Split?
Crossject has split 2 times. (See the ALCJ stock split history page for full effective split date and price information.)
How Many Employees Does Crossject Have?
Crossject has 103 employees.
What is the current trading status of Crossject (ALCJ)?
As of 24 Dec 2025, Crossject (ALCJ) is trading at a price of 2.175, with a previous close of 2.170. The stock has fluctuated within a day range of 2.150 to 2.200, while its 52-week range spans from 0.720 to 2.695.
What Is Crossject (ALCJ) Price Target According to Analysts?
The average 12-month price target for Crossject is EUR4.3, with a high estimate of EUR4.3 and a low estimate of EUR4.3. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +97.70% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.